Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 27, 2016 08:00 ET | Source: Kane Biotech Inc.

Kane Biotech Announces Private Placement Offering

WINNIPEG, MANITOBA--(Marketwired - Jan. 27, 2016) - Kane Biotech Inc. (TSX VENTURE:KNE) (the "Company" or "Kane Biotech") today announced the intention of the Company to undertake a...
January 08, 2016 08:00 ET | Source: Kane Biotech Inc.

Kane Biotech Receives $240,000 From Warrant Exercise

WINNIPEG, MANITOBA--(Marketwired - Jan. 8, 2016) - Kane Biotech Inc. (TSX VENTURE:KNE) (the "Corporation") announced that between December 30, 2015 and January 4, 2016 it received...
January 05, 2016 08:00 ET | Source: Kane Biotech Inc.

Kane Biotech Appoints New CFO and Announces Addition of Commercialization Team Resources, Sales Representation Agreement for U.S. Market Expansion, and Grant of Options

WINNIPEG, MANITOBA--(Marketwired - Jan. 5, 2016) - Kane Biotech Inc. (TSX VENTURE:KNE) (the "Corporation"), a biotechnology company developing and commercializing products that prevent...
December 31, 2015 08:00 ET | Source: Kane Biotech Inc.

Kane Biotech Announces Issuance of Common Shares in Payment of Outstanding Interest

WINNIPEG, MANITOBA--(Marketwired - Dec. 31, 2015) - Kane Biotech Inc. (TSX VENTURE:KNE) (the "Corporation") announced that on December 30, 2015, it issued 251,392 common shares of the...
December 16, 2015 06:00 ET | Source: Philip Renaud, Chairman and a Director of Kane Biotech Inc.

Philip Renaud Files Updated Early Warning Report in Respect of Kane Biotech Inc.

LONDON, UNITED KINGDOM--(Marketwired - Dec. 16, 2015) - Philip Renaud, the Chairman and a director of Kane Biotech Inc. (the "Corporation"), today announces that he and the Corporation...
December 14, 2015 07:00 ET | Source: Kane Biotech Inc.

Kane Biotech Announces Amendments to Terms of Convertible Note and Warrants

WINNIPEG, MANITOBA--(Marketwired - Dec. 14, 2015) - Kane Biotech Inc. (TSX VENTURE:KNE) (the "Corporation" or "Kane Biotech") today announced that the Corporation has entered into an...
November 10, 2015 07:00 ET | Source: Kane Biotech Inc.

Kane Biotech Receives $300,000 from Warrant Exercise

WINNIPEG, MANITOBA--(Marketwired - Nov. 10, 2015) - Kane Biotech Inc. (TSX VENTURE:KNE) (the "Corporation") announced that on November 5, 2015 it received $300,000 from the exercising of...
September 23, 2015 07:00 ET | Source: Kane Biotech Inc.

Kane Biotech Announces Issuance of Common Shares in Payment of Outstanding Interest

WINNIPEG, MANITOBA--(Marketwired - Sept. 23, 2015) - Kane Biotech Inc. (TSX VENTURE:KNE) (the "Corporation") announced that on September 22, 2015, it issued 254,178 common shares of the...
August 21, 2015 07:00 ET | Source: Kane Biotech Inc.

Kane Biotech Announces Financing Update

WINNIPEG, MANITOBA--(Marketwired - Aug. 21, 2015) - Kane Biotech Inc. (TSX VENTURE:KNE) ("Kane Biotech" or the "Company"), a biotechnology company engaged in the development and...
August 04, 2015 07:00 ET | Source: Kane Biotech Inc.

Kane Biotech and the U.S. Army Institute of Surgical Research Sign Cooperative Research and Development Agreement Extension

WINNIPEG, MANITOBA--(Marketwired - Aug. 4, 2015) - Kane Biotech Inc. (TSX VENTURE:KNE), a biotechnology company engaged in the development and commercialization of products that prevent...